BEXIMCO PHARMA.GDR REGS 1 Free Cash Flow Generation Index
BEXIMCO PHARMA.GDR REGS 1 free cash flow generation index. BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Free Cash Flow Generation Index of 0.73x as of June 2024. Free cash flow of €6.13 Billion represents 1% of operating cash flow (€8.36 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of BEXIMCO PHARMA.GDR REGS 1 (2022–2024)
Free cash flow generation index of BEXIMCO PHARMA.GDR REGS 1 from 2022 to 2024. Historical FCF Generation Index trend for BEXIMCO PHARMA.GDR REGS 1 across 3 annual periods. See BEXIMCO PHARMA.GDR REGS 1 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
BEXIMCO PHARMA.GDR REGS 1 Free Cash Flow Generation Index by Year (2022–2024)
BEXIMCO PHARMA.GDR REGS 1 free cash flow generation index by year from 2022 to 2024. Year-by-year Free Cash Flow Generation Index for BEXIMCO PHARMA.GDR REGS 1. For the full cash flow conversion analysis, see BEXIMCO PHARMA.GDR REGS 1 cash flow conversion.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.73x | €6.13 Billion | €8.36 Billion | €2.23 Billion | ▲ +32.1% |
| 2023 | 0.55x | €3.37 Billion | €6.08 Billion | €2.71 Billion | ▲ +27.1% |
| 2022 | 0.44x | €2.27 Billion | €5.21 Billion | €2.94 Billion | — |